Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$124.33 - $156.75 $38.8 Million - $49 Million
-312,300 Reduced 90.57%
32,500 $4.06 Million
Q2 2024

Aug 14, 2024

SELL
$113.33 - $163.85 $49.7 Million - $71.8 Million
-438,200 Reduced 55.96%
344,800 $54.5 Million
Q1 2024

May 15, 2024

SELL
$93.7 - $141.53 $17 Million - $25.7 Million
-181,300 Reduced 18.8%
783,000 $101 Million
Q4 2023

Feb 14, 2024

BUY
$67.31 - $124.76 $20.7 Million - $38.5 Million
308,200 Added 46.97%
964,300 $93 Million
Q3 2023

Nov 14, 2023

BUY
$102.5 - $123.59 $40.5 Million - $48.8 Million
394,700 Added 150.99%
656,100 $79.5 Million
Q2 2023

Aug 14, 2023

SELL
$106.4 - $157.19 $5.85 Million - $8.65 Million
-55,000 Reduced 17.38%
261,400 $29.9 Million
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $2.12 Million - $2.81 Million
18,000 Added 6.03%
316,400 $43.6 Million
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $12.2 Million - $16 Million
121,000 Added 68.21%
298,400 $38.7 Million
Q3 2022

Nov 14, 2022

SELL
$75.71 - $119.24 $1.55 Million - $2.44 Million
-20,500 Reduced 10.36%
177,400 $19.6 Million
Q2 2022

Aug 15, 2022

BUY
$62.69 - $88.44 $5.83 Million - $8.22 Million
93,000 Added 88.66%
197,900 $14.8 Million
Q1 2022

May 13, 2022

SELL
$63.15 - $90.42 $13.4 Million - $19.2 Million
-212,600 Reduced 66.96%
104,900 $8.2 Million
Q4 2021

Feb 11, 2022

BUY
$77.28 - $99.42 $20.7 Million - $26.7 Million
268,400 Added 546.64%
317,500 $28.6 Million
Q3 2021

Nov 12, 2021

SELL
$65.97 - $92.48 $2.12 Million - $2.98 Million
-32,200 Reduced 39.61%
49,100 $4.54 Million
Q2 2021

Aug 16, 2021

BUY
$69.38 - $86.75 $5.64 Million - $7.05 Million
81,300 New
81,300 $6.32 Million
Q1 2021

May 17, 2021

SELL
$72.25 - $168.95 $4.7 Million - $11 Million
-65,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$125.56 - $178.74 $6.91 Million - $9.83 Million
55,000 Added 550.0%
65,000 $11.1 Million
Q3 2020

Nov 16, 2020

SELL
$127.12 - $172.34 $5.08 Million - $6.89 Million
-40,000 Reduced 80.0%
10,000 $1.4 Million
Q2 2020

Aug 14, 2020

SELL
$93.0 - $171.7 $9.77 Million - $18 Million
-105,000 Reduced 67.74%
50,000 $8.02 Million
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $5.77 Million - $9.21 Million
70,000 Added 82.35%
155,000 $15.2 Million
Q4 2019

Feb 13, 2020

BUY
$76.53 - $135.58 $765,300 - $1.36 Million
10,000 Added 13.33%
85,000 $11 Million
Q3 2019

Nov 14, 2019

SELL
$72.81 - $156.91 $211,149 - $455,039
-2,900 Reduced 3.72%
75,000 $5.65 Million
Q2 2019

Aug 13, 2019

BUY
$112.21 - $151.95 $7.62 Million - $10.3 Million
67,900 Added 679.0%
77,900 $11.8 Million
Q1 2019

May 14, 2019

BUY
$106.67 - $151.68 $1.07 Million - $1.52 Million
10,000 New
10,000 $1.19 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.55B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.